聚乙二醇干扰素α通过IFN-γ增强慢性乙型肝炎中自然杀伤细胞对调节性T细胞的抑制作用
该研究纳入116例核苷(酸)类似物(NA)治疗的慢性乙型肝炎(CHB)患者,发现NK细胞与Treg频率呈负相关,NK细胞通过分泌IFN-γ抑制Treg增殖与分化,且PegIFN-α可增强该抑制,与更强的HBV特异性T细胞应答及HBsAg显著下降相关。
要点
- NA经治CHB患者中NK细胞与Treg频率呈负相关。
- NK细胞通过分泌IFN-γ抑制Treg增殖与分化。
- PegIFN-α增强NK对Treg的抑制并与HBsAg下降相关。
核心结论
- NK细胞通过IFN-γ抑制Treg增殖与分化,PegIFN-α可增强该抑制并与更强HBV特异性T细胞应答及HBsAg显著下降相关。
研究设计与样本
- 研究纳入116例接受核苷(酸)类似物(NA)治疗的慢性乙型肝炎(CHB)患者,并结合HBV携带小鼠模型肝脏进行验证。
主要发现
- 在PegIFN-α为基础治疗的NA抑制患者中,外周NK细胞频率与Treg频率呈负相关。
- NK细胞通过分泌IFN-γ抑制Treg的增殖与分化,证据见于NA治疗CHB患者循环及HBV携带小鼠肝脏。
- PegIFN-α治疗可增强NK细胞对Treg的抑制,且与更强的HBV特异性T细胞应答及HBsAg显著下降相关。
临床怎么用
- 提示PegIFN-α可通过增强NK细胞对Treg的抑制来改善CHB免疫治疗,为临床应用提供理论依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The immunomodulatory role of natural killer (NK) cells has been recognized recently, but its effects on CD4+CD25+ regulatory T cells (Tregs) during chronic hepatitis B (CHB) infection and treatment remain unclear. A total of 116 nucleos(t)ide analogue (NA)-treated CHB patients were included. An inverse correlation between the peripheral frequencies of NK cells and Tregs was found in NA suppressed patients following pegylated interferon-ɑ (PegIFN-ɑ)-based treatment. Furthermore, NK cells suppressed the proliferation and differentiation of Tregs through secreting IFN-γ as was evidenced in the circulation of NA-treated CHB patients as well as in liver of HBV-carrier mouse model. Additionally, the inhibition could be enhanced by PegIFN-ɑ treatment, which was correlated to more vigorous HBV-specific T-cell responses and marked reduction in HBsAg. Our study reveals a novel immunomodulatory mechanism of NK cells and provides a theoretical basis for PegIFN-ɑ as an immunotherapy agent in treating patients with CHB.
引用
- Yuan W, Huang D, Wu D, et al. Pegylated Interferon-ɑ (IFN-ɑ) Enhances the Inhibitory Effect of Natural Killer Cells on Regulatory T Cells via IFN-γ in Chronic Hepatitis B. J Infect Dis. 2021. PMID: 33870432. doi:10.1093/infdis/jiab216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。